Price Alert

VistaGen Therapeutics Inc... (VTGN)

NASDAQ: VTGN · Real-Time Price · USD

3.27

0.31 (10.66%)

At close: Aug 15, 2025, 2:36 PM

10.66% (1D)

Bid	3.27
Market Cap	100.48M
Revenue (ttm)	486K
Net Income (ttm)	-51.42M
EPS (ttm)	-1.79
PE Ratio (ttm)	-1.83
Forward PE	-1.78
Analyst	n/a

Ask	3.31
Volume	4,802,074
Avg. Volume (20D)	303,275
Open	2.97
Previous Close	2.96
Day's Range	2.95 - 3.34
52-Week Range	1.90 - 3.79
Beta	0.40

About VTGN

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol VTGN

Website n/a

Full Company Profile

Earnings Surprise

VistaGen Therapeutics has released their quartely earnings on Aug 7, 2025:

Revenue of $244K misses estimates by $145.4K, with 190.48% YoY growth.

EPS of -0.47 misses estimates by -0.02, with -34.29% YoY decline.

Next Earnings Release

VistaGen Therapeutics Inc. is scheduled to release its earnings on Nov 6, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

News

1 week ago · seekingalpha.com

Vistagen Therapeutics, Inc. (VTGN) Q1 2026 Earnings Call Transcript

Vistagen Therapeutics, Inc. (NASDAQ:VTGN ) Q1 2026 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Cynthia Lynn Anderson - VP & Chief Financial Officer Joshua S. Prince - Chief...

1 week ago · fool.com

Vistagen (VTGN) Q1 R&D Expense Jumps 54%

1 week ago · zacks.com

VistaGen Therapeutics, Inc. (VTGN) Reports Q1 Loss, Misses Revenue Estimates

VistaGen Therapeutics, Inc. (VTGN) came out with a quarterly loss of $0.47 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.35 per share a year ago.

1 week ago · businesswire.com

Vistagen Reports Fiscal Year 2026 First Quarter Financial Results and Corporate Update

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commerci...

Vistagen Therapeutics, Inc. (NASDAQ:VTGN ) Q4 2025 Earnings Conference Call June 17, 2025 5:00 PM ET Company Participants Cynthia Lynn Anderson - VP & Chief Financial Officer Mark Adrian McPartland - ...